Arcweave vs Neurolytics: Revenue, Funding & Team Size Compared
Arcweave generates $1.2M in revenue; Neurolytics generates $1.2M. Arcweave and Neurolytics are close to the same size by revenue. The table below compares Arcweave and Neurolytics on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company |  ArcweaveThis company |  Neurolytics |
|---|---|---|
| Revenue | $1.2M | $1.2M |
| Team size | 11 | 11 |
| Founded | 2018 | 2017 |
| HQ | United States | United States |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
Arcweave at a glance
Arcweave generates $1.2M in revenue with 11 employees, headquartered in United States.
- Revenue
- $1.2M
- Team size
- 11
- Founded
- 2018
Arcweave is a collaborative AI-powered cloud platform for creating games and immersive interactive experiences. It provides an easy-to-learn one stop solution for narrative, content management and prototyping needs. With its seamless…
Neurolytics at a glance
Neurolytics generates $1.2M in revenue with 11 employees, headquartered in United States.
- Revenue
- $1.2M
- Team size
- 11
- Founded
- 2017
❗️We enable small businesses to succeed in candidate selection with objective behavioral analytics 💡 Our SaaS solution helps hiring teams harness the power of AI and video-technology, with a company specific scan that candidates can…
Other Arcweave alternatives
Arcweave competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
Arcweave vs Neurolytics: frequently asked questions
Is Arcweave or Neurolytics bigger?
Arcweave is the bigger company by revenue, at $1.2M against $1.2M for Neurolytics.
How much revenue does Arcweave make?
Arcweave generates $1.2M in annual revenue with a team of 11.
How much revenue does Neurolytics make?
Neurolytics generates $1.2M in annual revenue with a team of 11.